Edit |   |
---|---|
Antigenic Specificity | CD123, Human (Talacotuzumab biosimilar) |
Clone | Talacotuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD123 Recombinant Antibody (Talacotuzumab). Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG. The drug is in phase II clinical trials as of January 2013. |
Immunogen | n/a |
Other Names | Anti-CD123 Recombinant Antibody, Research Grade Talacotuzumab, Anti-Human CD123 Recombinant Antibody(Talacotuzumab), CSL-362-AML, CSL362, JNJ-56022473, Antibody Drug Analogues, Monoclonal Antibody, YR1468, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1826831-79-1 |
Catalog # | YR1468 |
Price | please inquire |
Order / More Info | CD123, Human (Talacotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |